Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness.
about
Imaging of prehospital stroke therapeuticsCurrent controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand?Magnesium in stroke treatment.Anesthesia for endovascular neurosurgery.Methodology of the Field Administration of Stroke Therapy - Magnesium (FAST-MAG) phase 3 trial: Part 1 - rationale and general methodsPrehospital use of magnesium sulfate as neuroprotection in acute stroke.The role of magnesium in the management of cerebral vasospasm.Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage.Current and future perspectives on the treatment of cerebral ischemia.Poly (3,4-ethylenedioxythiophene) graphene oxide composite coatings for controlling magnesium implant corrosion.Intra-carotid cold magnesium sulfate infusion induces selective cerebral hypothermia and neuroprotection in rats with transient middle cerebral artery occlusion.Neuroprotection after major cardiovascular surgery.Relationship of serum magnesium concentration to risk of short-term outcome of acute ischemic stroke.Magnesium sulfate does not protect spinal cord against ischemic injury.Ginkgo biloba leaf extract (EGb761) combined with neuroprotective agents reduces the infarct volumes of gerbil ischemic brain.Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator-induced thrombolysis.Admission Low Magnesium Level Is Associated with In-Hospital Mortality in Acute Ischemic Stroke Patients.Self-powered therapeutic release from conducting polymer/graphene oxide films on magnesium.The Importance of Magnesium Values in Patients With STEMI Admitted to the Emergency Department.Hypomagnesemia in critically ill patients.Future advances in the treatment of acute ischemic stroke
P2860
Q26797275-9CBDD9CD-B2C8-4396-8048-648ADE864960Q26823280-9EE4A5FE-56E5-4765-A26E-EE549856349CQ35032195-F3DE51CD-EEF0-4512-A3EF-37DAA5877BD9Q36629801-622E1B0F-3725-4DF4-B079-54BCBDB20EDCQ37026056-B96EEAA4-B431-4B50-8469-43CAAFA1F664Q37036998-9A1B1086-8CCC-412D-AB9F-610C526F6B12Q38114437-267F9B1E-669B-4FA1-A38A-E65DCB4409D8Q38659372-CB1AE24E-0D84-4080-AB4F-7ABA0DA10CFAQ38732640-F36D6957-A04C-49A3-8E51-87B42AB691E1Q39170523-94FA53A2-B943-445F-B880-3DAE206C8E66Q47955438-5858938B-90E6-4355-8284-DC365A4DC28BQ48176970-0BF8AEEF-ED39-4B3D-A1B3-FB5125BAA638Q48199686-BE58C985-1DFC-405E-B0D5-406E66152EFCQ48217559-FE539143-1C36-4832-9827-FFFB44C537E5Q48380512-E6870459-0C0B-4F37-B6D0-AC92386E5131Q48522853-909FB868-603A-40FA-911B-1DAA7792949DQ48682377-753556E2-BD86-4A18-8B9C-3ABA671ACBADQ50719305-9374BD22-0002-40A4-AB38-7526ACA6AF40Q50856182-B045E229-C8C6-41D3-874F-EA22F7E462EBQ51640321-B5A67901-4331-41E4-992B-F27DAB670D1BQ55017757-19A1168F-4066-41C5-BD4F-162A1A28C157Q58619261-F4D4039D-1088-4A1E-B7C5-DB28615901C9
P2860
Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Magnesium for neuroprotection ...... and evidence of effectiveness.
@ast
Magnesium for neuroprotection ...... and evidence of effectiveness.
@en
Magnesium for neuroprotection ...... and evidence of effectiveness.
@nl
type
label
Magnesium for neuroprotection ...... and evidence of effectiveness.
@ast
Magnesium for neuroprotection ...... and evidence of effectiveness.
@en
Magnesium for neuroprotection ...... and evidence of effectiveness.
@nl
prefLabel
Magnesium for neuroprotection ...... and evidence of effectiveness.
@ast
Magnesium for neuroprotection ...... and evidence of effectiveness.
@en
Magnesium for neuroprotection ...... and evidence of effectiveness.
@nl
P1433
P1476
Magnesium for neuroprotection ...... and evidence of effectiveness.
@en
P2093
P304
P356
10.2165/00023210-200115120-00002
P577
2001-01-01T00:00:00Z
P6179
1012759748